Results 31 to 40 of about 1,846 (133)

A Case Report of Takayasu’s Arteritis

open access: yesJournal of Ophthalmology, 2017
Background: Takayasu’s arteritis is a non-specific autoimmune disease affecting large-size blood vessels, with a predilection for the aorta and its major branches.
O.O. Andrushkova   +4 more
doaj   +1 more source

The Role of Extracorporeal Membrane Oxygenation in Cardiopulmonary Dysfunction Due to Rheumatologic Diseases: A Systematic Review

open access: yesACR Open Rheumatology, Volume 8, Issue 4, April 2026.
Objective This systematic review documents the current status of extracorporeal membrane oxygenation (ECMO) use in patients with complications of rheumatologic diseases. Methods Following Preferred Reporting Items for Systematic Reviews and Meta Analyses 2020 guidelines, we conducted a systematic review of studies published from January 2019 to ...
Kari L. Falaas   +3 more
wiley   +1 more source

Takayasu’s Arteritis Presenting as Ischemic Stroke in Young Patient

open access: yesJournal of Rawalpindi Medical College, 2019
Takayasu’s arteritis is a chronic inflammatory vasculopathy. It commonly affects large blood vessels like aorta and its branches. Disease prevalence is more in women in second to third decade of life.
Sehrish Iqbal   +5 more
doaj  

Rare Gain‐of‐Function Variants in IDH1 and IDH2 Confer Increased Risk of Immune‐Mediated Rheumatic Diseases

open access: yesACR Open Rheumatology, Volume 8, Issue 4, April 2026.
Objective Gain‐of‐function variants in IDH1 and IDH2 are enriched among individuals with coexisting myeloid neoplasms and autoimmune diseases. However, the association between IDH1/IDH2 variants and rheumatic diseases independent of hematologic neoplasms remains unclear. We investigated the association between rare gain‐of‐function and loss‐of‐function
Mahmut S. Kaymakci   +3 more
wiley   +1 more source

Posterior reversible encephalopathy syndrome with Lilliputian hallucinations secondary to Takayasu's arteritis

open access: yesRadiology Case Reports, 2020
Posterior Reversible Encephalopathy Syndrome (PRES) is a rare complication of Takayasu's Arteritis. A 54-year-old, right-handed woman presented with Lilliputian visual hallucinations, postprandial abdominal pain, blurred vision and headaches.
R.M. Dunne, MB, BCh, BAO   +7 more
doaj   +1 more source

Safety of Immune Checkpoint Inhibitors in Cancer Patients With Preexisting Autoimmune Vasculitis

open access: yesACR Open Rheumatology, Volume 8, Issue 3, March 2026.
Objective Immune checkpoint inhibitors (ICIs) are effective cancer therapies but often cause serious immune‐related adverse events (irAEs). Patients with preexisting autoimmune diseases, including vasculitis, are excluded from trials. We aimed to evaluate the frequency, severity, and outcomes of vasculitis flares and irAEs in this population.
Juan Sevillano   +4 more
wiley   +1 more source

Takayasu’s arteritis occurring under TNF blockers in a patient with spondyloarthritis: is it an association or a paradoxical effect?

open access: yesRheumatology, 2021
Coexistence of spondyloarthritis (SpA) and Takayasu’s arteritis is not a common finding, but such cases have been discussed, particularly in the context of choice of therapy.
Amel Rezgui   +8 more
doaj   +1 more source

Exploring the Vasculitis‐Tumors Link: Epidemiological Patterns, Mechanistic Insights, and Clinical Implications

open access: yesAdvanced Science, Volume 13, Issue 14, 9 March 2026.
This review outlines association between vasculitis and malignancies and provides practical value for clinicians in distinguishing primary vasculitis from malignancy‐associated forms and optimizing patient surveillance, improving recognition of tumor‐associated vasculitis to reduce the risk of misdiagnosis, supporting more accurate clinical decision ...
Xiaofei Shi   +8 more
wiley   +1 more source

Takayasu's arteritis causing coronary stenosis with myocardial ischemia, severe aortic regurgitation, and pericarditis

open access: yesRadiology Case Reports
Takayasu's Arteritis (TA) is a rare, chronic large-vessel vasculitis that can lead to severe cardiac complications and life-threatening outcomes. Early diagnosis is essential for improving patient prognosis, but its nonspecific clinical presentation and ...
Ana Álvarez Vázquez, MD   +8 more
doaj   +1 more source

Glucagon‐Like Peptide 1 Receptor Agonists, Sodium‐Glucose Cotransporter 2 Inhibitors, and Risk of Autoimmune Rheumatic Diseases

open access: yesArthritis &Rheumatology, Volume 78, Issue 3, Page 654-664, March 2026.
Objective Glucagon‐like peptide 1 receptor agonists (GLP‐1RAs) and sodium‐glucose cotransporter 2 inhibitors (SGLT2i) facilitate weight loss and exhibit immunomodulatory effects, but their impact on the risk of developing autoimmune rheumatic diseases (ARDs) is unclear.
Derin Karacabeyli   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy